Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Novel gadolinium-based mifepristone conjugates were synthesised using various synthetic routes. Moderate antiprogestagenic activity of the new conjugates was observed in human breast cancer cells (T47-D cells) using AP (alkaline phosphatase) assay. The amount of incorporated Gd determined by inductively coupled plasma mass spectroscopy (ICPMS) indicates the number of binding sites per cell. These conjugates might be important compounds to develop receptor-targeted MRI contrast agents as well as other anti-breast cancer therapeutics.

Knowledge Graph

Similar Paper

Synthesis, in vitro progesterone receptors affinity of gadolinium containing mifepristone conjugates and estimation of binding sites in human breast cancer cells
Bioorganic & Medicinal Chemistry 2010.0
Syntheses and Antigestagenic Activity of Mifepristone Derivatives
Journal of Medicinal Chemistry 2009.0
Synthesis and preliminary evaluation steroidal antiestrogen–geldanamycin conjugates
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis of some steroidal mitocans of nanomolar cytotoxicity acting by apoptosis
European Journal of Medicinal Chemistry 2020.0
Synthesis and identification of novel 11β-aryl-4′,5′-dihydrospiro[estra-4,9-diene-17β,4′-oxazole] analogs with dissociated antiprogesterone activities
Bioorganic & Medicinal Chemistry Letters 2007.0
Design, Synthesis, and Bioactivities of Steroid-Linked Taxol Analogues as Potential Targeted Drugs for Prostate and Breast Cancer
Journal of Natural Products 2004.0
Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists
Bioorganic & Medicinal Chemistry Letters 2007.0
An Evaluation of a C-Glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and biological activities of nucleoside–estradiol conjugates
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)
Journal of Medicinal Chemistry 2019.0